World Journal of Surgical Oncology

Table 2 Adverse events

From: Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

	Grade
	I	II	III	IV
Hematological toxicity
Leukopenia	1 (6.3%)	0	0	0
Anemia	2 (11.1%)	1 (6.3%)	0	0
Thrombocytopenia	0	0	0	0
Non-hematological toxicity
Nausea/Vomiting	2 (11.1%)	2 (11.1%)	0	0
Diarrea	1 (6.3%)	0	0	0
Dysgeusia	1 (6.3%)	0	0	0
transamirase increased	0	1 (6.3%)	1 (6.3%)	0

Back to article page

ISSN: 1477-7819

Contact us

General enquiries: journalsubmissions@springernature.com